Prosecution Insights
Last updated: April 19, 2026

Examiner: AUDET, MAURY A

Tech Center 1600 • Art Units: 1654 1658 1675

This examiner grants 50% of resolved cases

Performance Statistics

50.3%
Allow Rate
-9.7% vs TC avg
1001
Total Applications
+23.5%
Interview Lift
1347
Avg Prosecution Days
Based on 942 resolved cases, 2023–2026

Rejection Statute Breakdown

3.8%
§101 Eligibility
11.8%
§102 Novelty
33.9%
§103 Obviousness
29.4%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
16630271 COMPOSITIONS AND METHODS FOR TREATING MYELIN DISORDERS Non-Final OA CASE WESTERN RESERVE UNIVERSITY
17630419 ANTICANCER AGENT AND METHOD FOR PREPARATION OF POROUS SILICA PARTICLE Non-Final OA LEMONEX INC.
18247465 METHODS FOR TREATING EYE DISEASES USING LIPID BINDING PROTEIN-BASED COMPLEXES Non-Final OA ABIONYX PHARMA SA
18247431 METHODS FOR THE TREATMENT OF AUTOIMMUNE PULMONARY ALVEOLAR PROTEINOSIS Non-Final OA Savara Inc.
18027731 NEW DOSAGE REGIMEN FOR INHALED VASOACTIVE INTESTINAL POLYPEPTIDE Non-Final OA CENTURION ILAÇ SANAYI VE TICARET ANONIM SIRKETI
17263676 COMPOSITIONS IN THE FORM OF AN AQUEOUS INJECTABLE SOLUTION COMPRISING AMYLIN, AN AMYLIN RECEPTOR AGONIST OR AN AMYLIN ANALOG, AT LEAST ONE IONIC SPECIES AND ONE AMPHIPHILIC COMPOUND BEARING HYDROPHOBIC RADICALS Final Rejection ADOCIA
17822099 IDENTIFICATION OF BIOMIMETIC VIRAL PEPTIDES AND USES THEREOF Non-Final OA LIGANDAL, INC.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month